USPTO 2015–2025 USPTO PatentsView US Corporation

Cellino Biotech, Inc.

USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

27.3

Avg claims per patent

5-year filing velocity

The verdict

Cellino holds 9 US patents across 11 technology areas, rank #28,442 of 50,000 tracked assignees.

#28,442
of 50,000 US assignees by volume: Top 8%
by Innovation Score (54.7/100): 27.3
avg claims per patent

Portfolio overview

Cellino Biotech, Inc. has been granted 9 US utility patents between 2023 and 2025, placing Cellino Biotech, Inc. at rank #28,442 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.3 claims per patent with primary concentration in C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). As a US Corporation, Cellino Biotech, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Cellino sits between Celanese EVA Performance Polymers Llc (9 patents, rank #28,438) and Central Adelaide Local Health Network Incorporated (9 patents, rank #28,446) - the closest US assignees by grant volume. The composite Innovation Score of 54.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cellino Biotech, Inc.'s 27.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cellino Biotech, Inc. against peers pursuing similar technology classes.

Celanese EVA Perf…

9
Celcuity

9
Celeno Communicat…

9
Cell Medica

9
Cellsec

9
Cellutech AB

9
Center Vue S p A

9
Central Adelaide…

9
Cellino Biotech ◀

9

What this shows Cellino holds 9 patents at rank #28,442, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cellino

By rank, the assignees closest to #28,442 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Cellino's primary technology class.

Cellino's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 8% higher than 92% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Cellino Biotech, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	3	33.3%
2024	4	44.4%
2025	2	22.2%

Which technologies does Cellino Biotech, Inc. patent most?

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 9

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 9

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 7

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 7

G03F - PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR; 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 1

B82Y - SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES 1

H01S - DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL 1

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 1

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Where it ranks

Overall rank by patents

#28,442

Across all tracked assignees

Innovation Score

54.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cellino Biotech, Inc. hold?

Cellino Biotech, Inc. holds 9 US granted patents filed between 2023 and 2025, spanning 11 technology areas.

What is Cellino Biotech, Inc.'s Innovation Score?

Cellino Biotech, Inc. has an Innovation Score of 54.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cellino Biotech, Inc. focus on?

Cellino Biotech, Inc.'s top technology area is C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS) with 9 patents. The company has filed patents in 11 CPC subclasses total.

Is Cellino Biotech, Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cellino Biotech, Inc..

What does claim depth mean for Cellino Biotech, Inc.'s patents?

Cellino Biotech, Inc.'s patents average 27.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Cellino Biotech, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cellino's 9 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cellino ranks #28,442 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12M - see who else leads that technology area. C12M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.